Pay in 4 interest-free payments of $5.99 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
How PT-141 Started as a Sexual Molecule Before Evolving in Women's Health Originally developed for erectile dysfunction in men, PT-141 targeted melanocortin pathways, where research showed MC4R elevation could cause signaling inefficiency in arousal circuits.[4][5] Early studies focused on its ability to activate these receptors, improving response times and satisfaction in models of sexual dysfunction.[2][3] This made it popular for HSDD research, with women reporting not just physical but emotional benefits, positioning it as a breakthrough for female-specific needs
The Vasculyse device is used to deliver a small electrical current directly to the blood vessels
Your appetite suppression may lessen for a few days
For comparison, the SURMOUNT-1 trial for tirzepatide showed an average of 20.9% weight loss at the highest dose over 72 weeks
US$ 20.01
US$ 27.40
US$ 26.70
US$ 28.23
US$ 26.43
US$ 21.88
US$ 23.76
US$ 26.85
US$ 28.62
US$ 24.17
US$ 27.24
